Viridian Therapeutics has received FDA approval for Lumvoa, a treatment for thyroid eye disease (TED), and has begun treating patients. The company is now focusing on successfully launching Lumvoa and leveraging its commercial infrastructure for both Lumvoa and its investigational drug elegrobart. This strategy aims to improve operational efficiency and franchise economics. While the current valuation is high with no near-term asset-based safety net, future profitability depends on effective commercialization, reimbursement, and expense management. The outlook remains positive but requires close monitoring of launch progress and financial stability.
Viridian Therapeutics and its recent FDA approval for Lumvoa provide context for health sector activity. For readers following the health sector, here is Pluang's market snapshot as of Sep 17, 2026 21:11 WIB: Among 91 priced US health stocks tradable on Pluang, 59 rose and 31 fell today. Notable movers include Illumina, Inc. (ILMN) at USD 241.64 with a 1-day change of +5.55% and Pluang order activity of 97% Sell / 3% Buy, Ginkgo Bioworks Holdings Inc (DNA) at USD 7.44 with a 1-day change of +5.38%, and Citius Pharmaceuticals Inc (CTXR) at USD 0.58 with a 1-day change of +4.20% and Pluang order activity of 0% Sell / 100% Buy. Typical hold times on Pluang range from 11 to 86 days among these stocks.
Alphabet is predicted to announce that its Google Cloud division will achieve revenue growth exceeding 100% in its upcoming report on October 28. This significant growth highlights the expanding importance of cloud services in Alphabet's business str...
Chery Auto is showcasing its purpose-built Level 4 (L4) self-driving Robotaxi at its 2026 Global User Summit in Wuhu, China, and signing a strategic cooperation agreement with UAE-based company K2. The Robotaxi, designed from the ground up for autono...
Nine companies, including Broadcom and Verizon, have formally objected to the listing of tokenized versions of their shares by the OKX-ICE blockchain exchange. These tokenized stocks represent digital versions of shares but may lack shareholder right...
On October 16, Bitcoin's mining difficulty increased by 5.92%, the second-largest rise this year, making mining more costly without increasing Bitcoin rewards. This adjustment means miners must expend nearly 6% more computing power for the same payou...
Uniswap's (UNI) token reserves held on Binance decreased to about 72.9 million after a decline starting October 10. The token's price also dropped, closing at $7.15 on October 17, which is 21% lower than its $9.08 close on October 5. This reserve dec...
